CureVac plans global late-stage Covid-19 vaccine trial in fourth quarter

CureVac has dosed the first patient with its experimental Covid-19 vaccine in the trial taking place in Peru and Panama and expects data on older adults in the fourth quarter.

from Hindustan Times - world https://bit.ly/33fhC2Y
https://ift.tt/2zbki14